Xiong et al. showed that sophoridine reduced cisplatin resistance in lung cancer cells and inhibited the proliferation of NCI-H446, NCI-H460, and A549 cells by activating the Hippo-YAP signalling pathway and p53 protein. Here, TP53 is linked to lung carcinoma.